Vertex Pharmaceuticals (VRTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX)

VRTX 422.43

+0.3%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (351)	11/10/1999 12:59:00 AM
From: margie	Read Replies (1) of 1169

Haven't been following any of this, but fyi, there are some reports from the Liver Meeting in Dallas at Jules Levin's NATAP site about HCV treatment with IL-2 and protease inhibitors and SGP pegylated interferon natap.org Then "Reports from the 50th AASLD Liver Meeting in Dallas, November 5-9 (11/4/99) Conference Reports, 50th AASLD (America Association for the Study of Liver Diseases) Liver Meeting in Dallas, November 5-9

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next